United States Masitinib Market Report 2016

December 2016 | 103 pages | ID: U363FF282DFEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Masitinib

Revenue, means the sales value of Masitinib

This report studies sales (consumption) of Masitinib in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Bristol-Myers Squibb
• Eli Lilly and Company
• Merck & Co.
• Roche
• Taiho Pharmaceutical
• Sumitomo Dainippon Pharma

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Masitinib in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Masitinib Market Report 2016

1 MASITINIB OVERVIEW

1.1 Product Overview and Scope of Masitinib
1.2 Classification of Masitinib
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Masitinib
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Masitinib (2011-2021)
  1.4.1 United States Masitinib Sales and Growth Rate (2011-2021)
  1.4.2 United States Masitinib Revenue and Growth Rate (2011-2021)

2 UNITED STATES MASITINIB COMPETITION BY MANUFACTURERS

2.1 United States Masitinib Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Masitinib Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Masitinib Average Price by Manufactures (2015 and 2016)
2.4 Masitinib Market Competitive Situation and Trends
  2.4.1 Masitinib Market Concentration Rate
  2.4.2 Masitinib Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES MASITINIB SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Masitinib Sales and Market Share by Type (2011-2016)
3.2 United States Masitinib Revenue and Market Share by Type (2011-2016)
3.3 United States Masitinib Price by Type (2011-2016)
3.4 United States Masitinib Sales Growth Rate by Type (2011-2016)

4 UNITED STATES MASITINIB SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Masitinib Sales and Market Share by Application (2011-2016)
4.2 United States Masitinib Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES MASITINIB MANUFACTURERS PROFILES/ANALYSIS

5.1 Bristol-Myers Squibb
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Masitinib Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Bristol-Myers Squibb Masitinib Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Eli Lilly and Company
  5.2.2 Masitinib Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Eli Lilly and Company Masitinib Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Merck & Co.
  5.3.2 Masitinib Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Merck & Co. Masitinib Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Roche
  5.4.2 Masitinib Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Roche Masitinib Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Taiho Pharmaceutical
  5.5.2 Masitinib Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Taiho Pharmaceutical Masitinib Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Sumitomo Dainippon Pharma
  5.6.2 Masitinib Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Sumitomo Dainippon Pharma Masitinib Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview

6 MASITINIB MANUFACTURING COST ANALYSIS

6.1 Masitinib Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Masitinib

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Masitinib Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Masitinib Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES MASITINIB MARKET FORECAST (2016-2021)

10.1 United States Masitinib Sales, Revenue Forecast (2016-2021)
10.2 United States Masitinib Sales Forecast by Type (2016-2021)
10.3 United States Masitinib Sales Forecast by Application (2016-2021)
10.4 Masitinib Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Masitinib
Table Classification of Masitinib
Figure United States Sales Market Share of Masitinib by Type in 2015
Table Application of Masitinib
Figure United States Sales Market Share of Masitinib by Application in 2015
Figure United States Masitinib Sales and Growth Rate (2011-2021)
Figure United States Masitinib Revenue and Growth Rate (2011-2021)
Table United States Masitinib Sales of Key Manufacturers (2015 and 2016)
Table United States Masitinib Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Masitinib Sales Share by Manufacturers
Figure 2016 Masitinib Sales Share by Manufacturers
Table United States Masitinib Revenue by Manufacturers (2015 and 2016)
Table United States Masitinib Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Masitinib Revenue Share by Manufacturers
Table 2016 United States Masitinib Revenue Share by Manufacturers
Table United States Market Masitinib Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Masitinib Average Price of Key Manufacturers in 2015
Figure Masitinib Market Share of Top 3 Manufacturers
Figure Masitinib Market Share of Top 5 Manufacturers
Table United States Masitinib Sales by Type (2011-2016)
Table United States Masitinib Sales Share by Type (2011-2016)
Figure United States Masitinib Sales Market Share by Type in 2015
Table United States Masitinib Revenue and Market Share by Type (2011-2016)
Table United States Masitinib Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Masitinib by Type (2011-2016)
Table United States Masitinib Price by Type (2011-2016)
Figure United States Masitinib Sales Growth Rate by Type (2011-2016)
Table United States Masitinib Sales by Application (2011-2016)
Table United States Masitinib Sales Market Share by Application (2011-2016)
Figure United States Masitinib Sales Market Share by Application in 2015
Table United States Masitinib Sales Growth Rate by Application (2011-2016)
Figure United States Masitinib Sales Growth Rate by Application (2011-2016)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Masitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Bristol-Myers Squibb Masitinib Sales Market Share (2011-2016)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Masitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eli Lilly and Company Masitinib Sales Market Share (2011-2016)
Table Merck & Co. Basic Information List
Table Merck & Co. Masitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Co. Masitinib Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Masitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Masitinib Sales Market Share (2011-2016)
Table Taiho Pharmaceutical Basic Information List
Table Taiho Pharmaceutical Masitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Taiho Pharmaceutical Masitinib Sales Market Share (2011-2016)
Table Sumitomo Dainippon Pharma Basic Information List
Table Sumitomo Dainippon Pharma Masitinib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sumitomo Dainippon Pharma Masitinib Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Masitinib
Figure Manufacturing Process Analysis of Masitinib
Figure Masitinib Industrial Chain Analysis
Table Raw Materials Sources of Masitinib Major Manufacturers in 2015
Table Major Buyers of Masitinib
Table Distributors/Traders List
Figure United States Masitinib Production and Growth Rate Forecast (2016-2021)
Figure United States Masitinib Revenue and Growth Rate Forecast (2016-2021)
Table United States Masitinib Production Forecast by Type (2016-2021)
Table United States Masitinib Consumption Forecast by Application (2016-2021)